UCB's Keppra Gets FDA Nod UCB was yet again in the news recently after the US Food and Drug Administration approved its lead product, Keppra (levetiracetam), for use as adjunctive therapy for the treatment of partial onset seizures....
UCB's Keppra Gets FDA Nod - Analyst Blog UCBÂ ( UCBJF ) was in the news again recently after the US Food and Drug Administration (FDA) approved its lead product, Keppra (levetiracetam), for use as adjunctive therapy
Keppra® Approved By FDA For Childhood Seizures In the U.S., Keppra® has been approved as adjunctive therapy for partial onset seizures in adults and children aged four years and older with epilepsy. However the UCB recently announced that the U.S. Food and Drug Administration (FDA) has now approved to lower the age restriction to include infants from the age of one month and older with epilepsy. Professor Dr. Iris Loew-Friedrich, Chief ...
Press Release UCB announced today that the U.S. Food and Drug Administration (FDA) has approved Keppra® (levetiracetam) tablets and oral solution as adjunctive therapy in the treatment of partial onset seizures in adults and children one month of age and older with epilepsy.
FDA approves UCB's Keppra for treatment of partial onset seizures in infants UCB announced today that the U.S. Food and Drug Administration (FDA) has approved Keppra (levetiracetam) tablets and oral solution as adjunctive therapy in the treatment of partial onset seizures in adults and children one month of age and older with epilepsy.
New hypertension treatment device category created by Britain's National Health Service ( InterCure ) From today, RESPeRATE, the $300 respiratory modulator clinically-proven to lower blood pressure becomes the first non-drug hypertension treatment to be reimbursed by UK's National Health Service Drug Tariff under a newly created sub-section 'Devices for the adjunctive treatment of hypertension. The NHS pioneering decision to set up a new medical device category to supplement the ...
Clobazam - Wikipedia, the free encyclopedia Clobazam (marketed under the brand names Frisium, Urbanol and Onfi), is a drug which is a benzodiazepine derivative. It has been marketed as an anxiolytic since 1975 and an ...
Armodafinil - Wikipedia, the free encyclopedia Armodafinil (Nuvigil) is a stimulant-like drug produced by the pharmaceutical company Cephalon Inc., which was approved by the FDA on June 15, 2007. Armodafinil is an ...
In vitro fertilisation - Wikipedia, the free encyclopedia In vitro fertilisation (IVF) is a process by which egg cells are fertilised by sperm outside the body: in vitro. IVF is a major treatment in infertility when other methods of ...
Chronic periodontitis - Wikipedia, the free encyclopedia Chronic periodontitis is a common disease of the oral cavity consisting of chronic inflammation of the periodontal tissues that is caused by accumulation of profuse amounts of ...
Lacosamide - Wikipedia, the free encyclopedia Lacosamide (INN, formerly known as erlosamide) is a medication developed by UCB for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain marketed ...
Menatetrenone - Wikipedia, the free encyclopedia Menatetrenone (INN), also known as MK4, is a menaquinone compound used as a hemostatic agent and as adjunctive therapy for the pain of osteoporosis.
Zonisamide - Wikipedia, the free encyclopedia Zonisamide is a sulfonamide anticonvulsant approved for use as an adjunctive therapy in adults with partial-onset seizures for adults; infantile spasm, mixed seizure types of ...
Aldosterone antagonist - Wikipedia, the free encyclopedia Aldosterone antagonist refers to diuretic drugs which antagonize the action of aldosterone at mineralocorticoid receptors. This group of drugs is often used as adjunctive ...